The Estradiol 1 mg/ml/Estriol 4 mg/ml Topical Cream is a compounded medication that combines two forms of estrogen, estradiol and estriol, in a semisolid dosage form. This cream is specifically designed for topical application and is dispensed in a pump mechanism to ensure a convenient, controlled, and consistent delivery of the medication to the skin. The formulation is intended for localized treatment and is absorbed through the skin to exert its therapeutic effects.
This cream is commonly used in the management of menopausal symptoms such as hot flashes, vaginal dryness, and atrophy. Additionally, it may be prescribed for conditions related to estrogen deficiency and for the support of healthy skin structure in postmenopausal women. The combination of estradiol and estriol aims to provide a balanced approach to hormone replacement therapy, potentially offering benefits in terms of efficacy and safety profiles.
Patients are advised to use this medication as directed by their healthcare provider, and it is important to follow specific instructions regarding application sites and frequency of use to optimize treatment outcomes and minimize potential side effects.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Estradiol 1 mg/ml/Estriol 4 mg/ml Topical Cream is a compounded medication specifically designed to deliver a combination of estrogen hormones directly through the skin. This semisolid preparation is dispensed in a pump mechanism, which ensures a convenient, hygienic, and controlled application. The pump is calibrated to deliver a precise dose with each actuation, minimizing the risk of dosing errors and ensuring consistency in the amount of medication applied.
Estradiol and estriol, the active ingredients in this formulation, are naturally occurring estrogens. Estradiol is the most potent form of estrogen and is crucial for many processes in the body. Estriol is a weaker estrogen, which is thought to offer benefits without the same level of risk associated with stronger estrogens. The combination of these two estrogens in a 1:4 ratio provides a balanced approach to hormone therapy, aiming to alleviate symptoms associated with estrogen deficiency while potentially reducing the risks associated with estrogen replacement therapy.
This topical cream is primarily used in the treatment of menopausal symptoms such as hot flashes, vaginal dryness, and atrophy, as well as aiding in the prevention of osteoporosis. By applying the cream topically, the hormones are absorbed through the skin and directly enter the bloodstream, bypassing the liver and reducing the risk of systemic side effects. This localized delivery system can be particularly beneficial for patients who may not tolerate oral hormone therapies or for those who prefer a non-invasive administration route.
For patients, it is important to understand that this medication should be used under the guidance of a healthcare provider, with regular monitoring to adjust the dose as needed. Patients should apply the cream as directed by their prescriber, typically to clean, intact skin on areas recommended by the pharmacist or physician. For prescribers, it is crucial to consider the individual patient's hormone levels, medical history, and risk factors when determining the appropriateness of this therapy and the optimal dosing regimen.
As compounding pharmacists at Bayview Pharmacy, we are committed to providing high-quality, customized medications to meet the unique needs of each patient. We are available to answer any questions and provide additional information to both patients and prescribers regarding the use of this Estradiol/Estriol Topical Cream. Please do not hesitate to reach out to us for guidance or to discuss the potential benefits and risks associated with this compounded formulation.
The estradiol 1 mg/ml and estriol 4 mg/ml topical cream is a hormone replacement therapy primarily used to alleviate symptoms associated with menopause, such as hot flashes, vaginal dryness, and osteoporosis prevention. When considering drug interactions, it is important to note that the active ingredients, estradiol and estriol, are forms of estrogen. As such, they may interact with a variety of medications and substances.
Firstly, concurrent use of other hormonal therapies, particularly progestins or other estrogens, should be approached with caution. The combination may increase the risk of side effects and alter the intended hormone balance. Patients should inform their healthcare provider of any other hormone treatments they are using, including oral contraceptives or hormone-releasing intrauterine devices.
Enzyme inducers, such as certain anticonvulsants (e.g., phenytoin, carbamazepine) and antimicrobials (e.g., rifampicin), may increase the metabolism of estrogens, potentially reducing their effectiveness. Conversely, enzyme inhibitors like certain antifungals (e.g., ketoconazole) and protease inhibitors may increase estrogen levels, leading to an increased risk of side effects.
Thyroid function may be affected by estrogen therapy. Estrogens can increase thyroid-binding globulin (TBG) levels, which may alter the amount of thyroid hormone that is free and active in the body. Patients on thyroid hormone replacement therapy may require monitoring and possible dose adjustments.
Estrogens can also affect the metabolism of certain blood thinners, such as warfarin, leading to either an increased or decreased anticoagulant effect. Close monitoring of coagulation parameters and possible dose adjustment of the anticoagulant may be necessary when initiating or discontinuing estrogen therapy.
Grapefruit juice may increase plasma concentrations of estrogens and should be consumed with caution due to the potential for increased side effects. Additionally, smoking tobacco may reduce the efficacy of estrogen therapy and increase the risk of cardiovascular side effects, especially in women over 35 years of age.
It is also important to consider the potential for increased risk of certain types of cancers with estrogen use, particularly in patients with a history or family history of hormone-sensitive cancers. While this is not a direct drug interaction, it is a critical consideration for patient safety.
Patients should be advised to inform their healthcare providers of all medications, supplements, and herbal products they are taking to ensure proper management of potential interactions. If you have any questions or require further information about specific drug interactions with this topical cream formulation, please reach out to us at Bayview Pharmacy for assistance.
The Estradiol 1 mg/ml/Estriol 4 mg/ml Topical Cream is a hormone replacement therapy (HRT) designed to deliver a combination of estrogen hormones directly through the skin. Estradiol and estriol are forms of estrogen, a hormone produced by the ovaries, which regulates many processes in the female body. As women approach menopause, the natural production of estrogen decreases, leading to symptoms such as hot flashes, vaginal dryness, and osteoporosis. This topical cream aims to replenish the levels of estrogen in the body, thereby alleviating these menopausal symptoms.
The cream is formulated as a semisolid preparation, which allows for a smooth and consistent application over the skin. The inclusion of both estradiol and estriol in the formulation provides a synergistic effect, as estradiol is a potent form of estrogen with a wide range of physiological effects, while estriol is considered to have a more selective action with potentially fewer side effects. The combination of these estrogens can be beneficial in providing relief from menopausal symptoms while minimizing the risks associated with estrogen therapy.
The cream is dispensed in a pump mechanism, which is designed to deliver a measured dose of the medication with each pump. This ensures that the patient receives a consistent dose with each application, which is important for maintaining stable hormone levels. The pump also minimizes the risk of contamination and oxidation of the product, preserving its efficacy and shelf-life. The topical route of administration allows the hormones to be absorbed directly into the bloodstream through the skin, bypassing the gastrointestinal tract and liver, which can metabolize and inactivate oral estrogens, leading to a more efficient and targeted therapy.
When applied as directed, the Estradiol 1 mg/ml/Estriol 4 mg/ml Topical Cream can help to treat the symptoms of menopause by restoring the hormonal balance. It is important for patients to follow the prescribed dosing regimen and apply the cream to clean, dry skin, typically on the lower abdomen, thighs, or arms, as directed by their healthcare provider. Patients should be aware that hormone replacement therapy may not be suitable for everyone and that there are potential risks associated with estrogen use, including an increased risk of blood clots, stroke, and certain types of cancer. Therefore, it is essential to discuss the benefits and risks with a healthcare provider before starting treatment.
For prescribers considering this formulation for their patients, it is important to evaluate the patient's individual risk factors, such as personal and family medical history, and to consider the lowest effective dose for the shortest duration consistent with treatment goals. Regular follow-up and monitoring are recommended to assess the efficacy and safety of the treatment. If you have any questions or require further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to ensure the best possible outcomes for your patients.
This compounded cream is primarily used to help alleviate symptoms of menopause, such as hot flashes, vaginal dryness, and bone loss, by providing a combination of estrogen hormones (Estradiol and Estriol) directly to the affected area through the skin.
The cream should be applied as directed by your healthcare provider. It is commonly applied to clean, dry skin on areas such as the arms, thighs, or abdomen. Apply the cream using the pump mechanism to ensure a controlled dose is dispensed.
It is not recommended to apply this cream on the face unless instructed by your healthcare provider, as the skin on the face may be more sensitive, and it's not the intended site of application for menopausal symptom relief.
The number of pumps needed per application will be determined by your healthcare provider based on your condition and therapeutic needs. Follow the prescribed dosage instructions carefully.
Possible side effects include skin irritation at the site of application, nausea, bloating, breast tenderness, and headache. If you experience any severe side effects or signs of an allergic reaction, contact your healthcare provider immediately.
Estradiol/Estriol cream is generally not recommended for use during pregnancy or breastfeeding unless specifically prescribed by a healthcare provider. Be sure to discuss all risks with your provider before starting treatment.
It's suggested to wait at least one to two hours after applying the cream before swimming or showering to allow sufficient absorption. Consult with your healthcare provider for specific recommendations.
The medication should be stored at room temperature, away from direct heat and light. Do not freeze the cream, and keep the container tightly closed when not in use.
If you miss a dose, apply it as soon as you remember. If it’s close to the time for your next dose, skip the missed dose and proceed with your regular dosing schedule. Do not double up on doses to compensate for the missed one.
This medication is typically formulated for women dealing with menopausal symptoms and is not generally recommended for men. Men should consult with their healthcare provider before using any hormone replacement therapy.
Yes, this is a compounded medication that requires a prescription from a licensed healthcare provider. It is custom-made to meet the individual needs of patients based on a healthcare provider's specifications.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)